Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Fox

Showing results (301-310 of 322) with videos related to

Pageof 33
Sort By:
European Journal of Pharmacology|July 18, 1996
Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitorsN Fox, M Song, J Schrementi, et al.
Contemporary Clinical Trials|April 26, 2021
Rationale and design of a randomized factorial clinical trial of pharmacogenetic and adherence optimization strategies to promote tobacco cessation among persons with HIVMackenzie Hosie Quinn, Anna-Marika Bauer, Erica N Fox, et al.
Hepatology (Baltimore, Md.)|December 3, 2021
The use of nondirected donor organs in living donor liver transplantation: Perspectives and guidanceAlyson N Fox, AnnMarie Liapakis, Ramesh Batra, et al.
Geobiology|July 16, 2016
Microbialite response to an anthropogenic salinity gradient in Great Salt Lake, UtahM R Lindsay, C Anderson, N Fox, et al.
Neuroscience|March 31, 2020
A Role for PGC-1α in Transcription and Excitability of Neocortical and Hippocampal Excitatory NeuronsL J McMeekin, A F Bartley, A S Bohannon, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 23, 1999
Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPID W Snyder, N J Bach, R D Dillard, et al.
Cell|October 1, 2013
NCoR repression of LXRs restricts macrophage biosynthesis of insulin-sensitizing omega 3 fatty acidsPingping Li, Nathanael J Spann, Minna U Kaikkonen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 18, 2020
Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort studyMarcus R Pereira, Meghan M Aversa, Maryjane A Farr, et al.
Addiction (Abingdon, England)|April 17, 2023
Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trialBrian Hitsman, George D Papandonatos, Jacqueline K Gollan, et al.
NPJ Parkinson'S Disease|August 18, 2022
Estrogen-related receptor gamma regulates mitochondrial and synaptic genes and modulates vulnerability to synucleinopathyS N Fox, L J McMeekin, C H Savage, et al.
Pageof 33

Showing results (301-310 of 322) with videos related to

Sort By:
Pageof 33
European Journal of Pharmacology|July 18, 1996
Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitorsN Fox, M Song, J Schrementi, et al.
Contemporary Clinical Trials|April 26, 2021
Rationale and design of a randomized factorial clinical trial of pharmacogenetic and adherence optimization strategies to promote tobacco cessation among persons with HIVMackenzie Hosie Quinn, Anna-Marika Bauer, Erica N Fox, et al.
Hepatology (Baltimore, Md.)|December 3, 2021
The use of nondirected donor organs in living donor liver transplantation: Perspectives and guidanceAlyson N Fox, AnnMarie Liapakis, Ramesh Batra, et al.
Geobiology|July 16, 2016
Microbialite response to an anthropogenic salinity gradient in Great Salt Lake, UtahM R Lindsay, C Anderson, N Fox, et al.
Neuroscience|March 31, 2020
A Role for PGC-1α in Transcription and Excitability of Neocortical and Hippocampal Excitatory NeuronsL J McMeekin, A F Bartley, A S Bohannon, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 23, 1999
Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPID W Snyder, N J Bach, R D Dillard, et al.
Cell|October 1, 2013
NCoR repression of LXRs restricts macrophage biosynthesis of insulin-sensitizing omega 3 fatty acidsPingping Li, Nathanael J Spann, Minna U Kaikkonen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 18, 2020
Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort studyMarcus R Pereira, Meghan M Aversa, Maryjane A Farr, et al.
Addiction (Abingdon, England)|April 17, 2023
Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trialBrian Hitsman, George D Papandonatos, Jacqueline K Gollan, et al.
NPJ Parkinson'S Disease|August 18, 2022
Estrogen-related receptor gamma regulates mitochondrial and synaptic genes and modulates vulnerability to synucleinopathyS N Fox, L J McMeekin, C H Savage, et al.
Pageof 33